|
US20160279239A1
(en)
|
2011-05-02 |
2016-09-29 |
Immunomedics, Inc. |
Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
|
|
US8658773B2
(en)
|
2011-05-02 |
2014-02-25 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
|
USRE47770E1
(en)
|
2002-07-18 |
2019-12-17 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
|
DK2314629T4
(da)
|
2002-07-18 |
2023-02-06 |
Merus Nv |
Rekombinant produktion af blandinger af antistoffer
|
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
|
WO2004106375A1
(en)
|
2003-05-30 |
2004-12-09 |
Merus Biopharmaceuticals B.V. I.O. |
Fab library for the preparation of anti vegf and anti rabies virus fabs
|
|
SG128680A1
(en)
*
|
2003-07-22 |
2007-01-30 |
Crucell Holland Bv |
Binding molecules against sars-coronavirus and uses thereof
|
|
EP2314620B1
(en)
*
|
2004-05-27 |
2013-06-05 |
Crucell Holland B.V. |
Method of identifying binding molecules capable of neutralizing rabies virus
|
|
JP4852046B2
(ja)
*
|
2004-10-12 |
2012-01-11 |
クルセル ホランド ベー ヴェー |
癌の治療及び検出に用いる結合分子
|
|
US20160355591A1
(en)
|
2011-05-02 |
2016-12-08 |
Immunomedics, Inc. |
Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
|
|
WO2006120230A2
(en)
|
2005-05-12 |
2006-11-16 |
Crucell Holland B.V. |
Host cell specific binding molecules capable of neutralizing viruses and uses thereof
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
CA2881717C
(en)
*
|
2006-06-06 |
2018-06-12 |
Cecilia Anna Wilhelmina Geuijen |
Human binding molecules having killing activity against staphylococci and uses thereof
|
|
EP2450377A1
(en)
|
2006-09-07 |
2012-05-09 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
|
|
WO2008110937A2
(en)
*
|
2007-03-13 |
2008-09-18 |
Humabs Llc |
Antibodies against h5n1 strains of influenza a virus
|
|
CN101679974B
(zh)
|
2007-03-27 |
2015-09-30 |
航道生物技术有限责任公司 |
包含抗体替代轻链序列的构建体和文库
|
|
EP2036045A1
(en)
*
|
2007-07-11 |
2009-03-18 |
Cairos technologies AG |
Video tracking method and appartus arrangement for performing the method
|
|
EP2207804B1
(en)
*
|
2007-09-13 |
2015-07-22 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof
|
|
AU2008297594B2
(en)
|
2007-09-13 |
2013-06-20 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
|
|
RU2010127156A
(ru)
|
2007-12-06 |
2012-01-20 |
Дана-Фарбер Кэнсер Инститьют, Инк. (Us) |
Антитела против вируса гриппа и их применение
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
JP2011516423A
(ja)
*
|
2008-03-28 |
2011-05-26 |
シー レーン バイオテクノロジーズ， エルエルシー |
ウイルス抗原に対する中和分子
|
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
|
CA2731686C
(en)
*
|
2008-07-25 |
2020-04-07 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
GB0818356D0
(en)
*
|
2008-10-07 |
2008-11-12 |
Istituto Superiore Di Sanito |
Antibodies
|
|
AR073770A1
(es)
*
|
2008-10-20 |
2010-12-01 |
Imclone Llc |
Anticuerpo aislado que se enlaza especificamente con, e induce la degradacion del receptor-3 del factor de crecimiento del fibroblasto humano (fgfr-3), fragmento de enlace fgfr-3 humano del mismo, composicion farmaceutica y producto que lo comprenden
|
|
PL2350128T3
(pl)
|
2008-10-22 |
2015-03-31 |
Inst Res Biomedicine |
Sposoby wytwarzania przeciwciał z komórek plazmatycznych
|
|
JP5933975B2
(ja)
*
|
2008-11-12 |
2016-06-15 |
メディミューン，エルエルシー |
抗体製剤
|
|
AU2008365616A1
(en)
|
2008-12-24 |
2011-08-11 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof
|
|
WO2010117786A1
(en)
|
2009-03-30 |
2010-10-14 |
Mount Sinai School Of Medicine Of New York University |
Influenza virus vaccines and uses thereof
|
|
CA2760553A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Jr. James E. Crowe |
Monoclonal antibodies to influenza h1n1 virus and uses thereof
|
|
CA2761648C
(en)
*
|
2009-05-11 |
2019-03-12 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
CA2761681A1
(en)
|
2009-05-13 |
2010-11-18 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to influenza viruses
|
|
US8673314B2
(en)
|
2009-05-26 |
2014-03-18 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
|
WO2011019932A2
(en)
*
|
2009-08-14 |
2011-02-17 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
WO2011044570A2
(en)
*
|
2009-10-09 |
2011-04-14 |
Emory University |
Recombinant antibodies against h1n1 influenza
|
|
AU2011210840B2
(en)
*
|
2010-01-27 |
2014-12-11 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
|
EP2536425B1
(en)
|
2010-02-18 |
2019-06-19 |
Icahn School of Medicine at Mount Sinai |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
EP3098236A1
(en)
*
|
2010-03-08 |
2016-11-30 |
Celltrion, Inc. |
Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
|
|
CN102939103A
(zh)
|
2010-03-30 |
2013-02-20 |
西奈山医学院 |
流感病毒疫苗及其应用
|
|
CN102241768B
(zh)
*
|
2010-05-14 |
2013-12-25 |
中国科学院上海生命科学研究院 |
一种抗甲型h1n1流感病毒血凝素蛋白的抗体
|
|
KR101849738B1
(ko)
*
|
2010-06-17 |
2018-04-17 |
트렐리스 바이오싸이언스 인코포레이티드 |
수동 인플루엔자 면역에 유용한 항체
|
|
WO2012009790A1
(en)
|
2010-07-22 |
2012-01-26 |
Schrader John W |
Cross-protective pathogen protection, methods and compositions thereof
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CA2807664A1
(en)
*
|
2010-08-12 |
2012-02-16 |
Theraclone Sciences, Inc. |
Anti-hemagglutinin antibody compositions and methods of use thereof
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
US8883171B2
(en)
|
2010-09-14 |
2014-11-11 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Computationally optimized broadly reactive antigens for influenza
|
|
EP2625189B1
(en)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2663334A4
(en)
*
|
2011-01-10 |
2016-01-13 |
Univ Emory |
ANTIBODIES AGAINST INFLUENZA
|
|
WO2012112489A2
(en)
*
|
2011-02-14 |
2012-08-23 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
EA201391248A1
(ru)
*
|
2011-03-01 |
2014-05-30 |
Эмджен Инк. |
Биспецифические связывающие агенты
|
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US9580475B2
(en)
|
2011-06-20 |
2017-02-28 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Computationally optimized broadly reactive antigens for H1N1 influenza
|
|
US8961978B2
(en)
*
|
2011-07-14 |
2015-02-24 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses
|
|
AU2011373387B2
(en)
|
2011-07-18 |
2017-06-29 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
EP2736928B1
(en)
|
2011-07-28 |
2019-01-09 |
i2 Pharmaceuticals, Inc. |
Sur-binding proteins against erbb3
|
|
WO2013033319A2
(en)
*
|
2011-08-30 |
2013-03-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
A cluster of neutralizing antibodies to hepatitis c virus
|
|
GB201115214D0
(en)
|
2011-09-02 |
2011-10-19 |
Health Prot Agency |
Influenza virus antibody compositions
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP4241785B1
(en)
|
2011-09-20 |
2026-01-28 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
CA2791109C
(en)
|
2011-09-26 |
2021-02-16 |
Merus B.V. |
Generation of binding molecules
|
|
DE19216461T1
(de)
|
2011-10-03 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
|
WO2013059524A2
(en)
*
|
2011-10-18 |
2013-04-25 |
Emory University |
Antibodies directed against influenza
|
|
EP3566714A1
(en)
|
2011-11-28 |
2019-11-13 |
Janssen Vaccines & Prevention B.V. |
Influenza virus vaccines and uses thereof
|
|
EP2785737A2
(en)
*
|
2011-12-02 |
2014-10-08 |
AIMM Therapeutics B.V. |
Influenza a virus specific antibodies
|
|
MX367743B
(es)
|
2011-12-05 |
2019-09-04 |
Trellis Bioscience Llc |
Anticuerpos utiles para la inmunizacion pasiva de influenza.
|
|
WO2013089496A1
(ko)
*
|
2011-12-15 |
2013-06-20 |
(주)에이프로젠 |
H1n1-감염된 환자들로부터 유도된 매우 잠재력 있는 넓은-스펙트럼 중화 단일클론 항체 및 이를 포함하는 바이러스의 치료용 조성물
|
|
CA3018046A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US9975956B2
(en)
|
2011-12-22 |
2018-05-22 |
I2 Pharmaceuticals, Inc. |
Surrogate binding proteins which bind DR4 and/or DR5
|
|
WO2013119683A1
(en)
|
2012-02-07 |
2013-08-15 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses
|
|
CA2863949C
(en)
|
2012-02-13 |
2021-06-29 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for human and avian h5n1 influenza
|
|
SG11201405226TA
(en)
|
2012-03-08 |
2014-11-27 |
Crucell Holland Bv |
Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
|
|
CA2868330A1
(en)
|
2012-03-30 |
2013-10-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9248181B2
(en)
|
2012-04-20 |
2016-02-02 |
Merus B.V. |
Methods and means for the production of Ig-like molecules
|
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
|
EP2712626A1
(en)
|
2012-09-28 |
2014-04-02 |
Fabentech |
Passive immunisation against influenza, in particular H5N1
|
|
CN104968367B
(zh)
|
2012-11-13 |
2018-04-13 |
弗·哈夫曼-拉罗切有限公司 |
抗血凝素抗体和使用方法
|
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
|
SG11201503989PA
(en)
|
2012-11-27 |
2015-06-29 |
Univ Pittsburgh |
Computationally optimized broadly reactive antigens for h1n1 influenza
|
|
SG11201504728RA
(en)
|
2012-12-18 |
2015-07-30 |
Icahn School Med Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
US9908930B2
(en)
|
2013-03-14 |
2018-03-06 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
MX387277B
(es)
*
|
2013-03-14 |
2025-03-12 |
Contrafect Corp |
Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada.
|
|
US9624272B2
(en)
|
2013-03-14 |
2017-04-18 |
University Of Washington Through Its Center For Commercialization |
Polypeptides for treating and/or limiting influenza infection
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
WO2014161483A1
(zh)
*
|
2013-04-02 |
2014-10-09 |
厦门大学 |
识别流感病毒血凝素蛋白ha1结构域的广谱单克隆抗体
|
|
EA034639B1
(ru)
|
2013-05-30 |
2020-03-02 |
Янссен Вэксинс Энд Превеншн Б.В. |
Вакцины против вируса гриппа и их применения
|
|
EP3037533A4
(en)
|
2013-08-23 |
2017-07-05 |
Fujita Health University |
Anti-influenza virus-neutralizing antibody
|
|
EP3037819A4
(en)
*
|
2013-08-23 |
2017-03-29 |
Fujita Health University |
Method of determining resistance to influenza virus
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
SI3052192T1
(sl)
|
2013-10-02 |
2020-11-30 |
Medimmune, Llc |
Nevtralizarijoča protitelesa proti-influenci A in njihove uporabe
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
WO2015068781A1
(ja)
*
|
2013-11-06 |
2015-05-14 |
国立大学法人大阪大学 |
インフルエンザウイルスａ型のグループ１に対して広域な中和活性を有する抗体
|
|
JP6712428B2
(ja)
|
2014-02-04 |
2020-06-24 |
コントラフェクト コーポレイション |
インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法
|
|
US10639370B2
(en)
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
EP3105250B1
(en)
|
2014-02-10 |
2020-08-05 |
IGM Biosciences, Inc. |
Iga multi-specific binding molecules
|
|
EP4043489A1
(en)
|
2014-03-19 |
2022-08-17 |
Dana-Farber Cancer Institute, Inc. |
Immunogenetic restriction on elicitation of antibodies
|
|
PL4023249T3
(pl)
|
2014-04-23 |
2025-03-10 |
Modernatx, Inc. |
Szczepionki z kwasem nukleinowym
|
|
EA035375B1
(ru)
*
|
2014-07-10 |
2020-06-03 |
Янссен Вэксинс Энд Превеншн Б.В. |
Вакцины против вируса гриппа и их применения
|
|
MX378904B
(es)
|
2014-07-10 |
2025-03-10 |
Janssen Vaccines & Prevention Bv |
Vacunas para virus influenza y usos de las mismas.
|
|
MX392761B
(es)
|
2014-07-15 |
2025-03-21 |
Medimmune Llc |
Anticuerpos anti-influenza b neutralizantes y usos de los mismos.
|
|
TWI702229B
(zh)
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
US10736956B2
(en)
|
2015-01-23 |
2020-08-11 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccination regimens
|
|
WO2016124682A1
(en)
|
2015-02-05 |
2016-08-11 |
Janssen Vaccines & Prevention B.V. |
Human neutralizing antibodies binding to influenza neuraminidase
|
|
MY186585A
(en)
|
2015-02-05 |
2021-07-28 |
Janssen Vaccines & Prevention Bv |
Binding molecules directed against influenza hemagglutinin and uses thereof
|
|
EP3294753A1
(en)
|
2015-05-11 |
2018-03-21 |
Janssen Vaccines & Prevention B.V. |
Influenza virus neutralizing peptidomimetic compounds
|
|
HUE056407T2
(hu)
|
2015-06-01 |
2022-02-28 |
Medimmune Llc |
Neutralizáló influenzaellenes kötõmolekulák és alkalmazásaik
|
|
EP3374390A1
(en)
|
2015-11-13 |
2018-09-19 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
SG11201805001UA
(en)
|
2016-01-13 |
2018-07-30 |
Medimmune Llc |
Method of treating influenza a
|
|
AU2017222564A1
(en)
|
2016-02-24 |
2018-09-06 |
Visterra, Inc. |
Formulations of antibody molecules to influenza virus
|
|
WO2017148889A1
(en)
|
2016-03-01 |
2017-09-08 |
Janssen Vaccines & Prevention B.V. |
Human neutralizing antibodies binding to influenza b neuraminidase
|
|
MX2018015755A
(es)
|
2016-06-15 |
2019-08-29 |
Icahn School Med Mount Sinai |
Proteinas de hemaglutinina de virus de influenza y usos de las mismas.
|
|
KR101835009B1
(ko)
|
2016-08-19 |
2018-03-07 |
주식회사 하이딥 |
터치 입력 장치
|
|
AU2017345786B2
(en)
*
|
2016-10-21 |
2024-08-01 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
|
CN110035771B
(zh)
|
2016-10-21 |
2024-03-08 |
阿迪马布有限责任公司 |
抗呼吸道合胞病毒抗体及其产生和使用方法
|
|
US11479600B2
(en)
|
2016-10-21 |
2022-10-25 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
|
AU2017350304B2
(en)
|
2016-10-27 |
2022-03-03 |
Janssen Vaccines & Prevention B.V. |
Influenza virus neutralizing compounds
|
|
CA3051377A1
(en)
|
2017-01-27 |
2018-08-02 |
National Research Council Of Canada |
Hemagglutinin-specific antibodies and uses thereof
|
|
WO2018141854A1
(en)
|
2017-02-02 |
2018-08-09 |
Janssen Vaccines & Prevention B.V. |
Piperazine derivatives for influenza virus inhibition
|
|
EP3577107A1
(en)
|
2017-02-02 |
2019-12-11 |
Janssen Vaccines & Prevention B.V. |
Piperazine derivatives for influenza virus inhibition
|
|
AU2018219887B2
(en)
|
2017-02-08 |
2024-08-15 |
Dragonfly Therapeutics, LLC |
Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer
|
|
CN110944661A
(zh)
|
2017-02-20 |
2020-03-31 |
蜻蜓疗法股份有限公司 |
结合her2、nkg2d和cd16的蛋白质
|
|
US10799597B2
(en)
|
2017-04-03 |
2020-10-13 |
Immunomedics, Inc. |
Subcutaneous administration of antibody-drug conjugates for cancer therapy
|
|
US11254733B2
(en)
|
2017-04-07 |
2022-02-22 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza B virus neuraminidase antibodies and uses thereof
|
|
KR102119783B1
(ko)
*
|
2017-08-14 |
2020-06-08 |
사회복지법인 삼성생명공익재단 |
인간 상피 성장 인자 수용체 변이체 ⅲ에 결합하는 항체 및 그의 항체 단편
|
|
ES2960419T3
(es)
|
2017-09-15 |
2024-03-04 |
Lentigen Tech Inc |
Composiciones y métodos de tratamiento de cáncer con inmunoterapia anti-CD19
|
|
LT3743106T
(lt)
|
2018-01-23 |
2022-09-26 |
Janssen Vaccines & Prevention B.V. |
Gripo viruso vakcinos ir jų panaudojimo būdai
|
|
US11780907B2
(en)
|
2018-01-26 |
2023-10-10 |
Regeneron Pharmaceuticals, Inc. |
Human antibodies to influenza hemagglutinin
|
|
BR112020015994A2
(pt)
|
2018-02-08 |
2020-12-15 |
Dragonfly Therapeutics, Inc. |
Terapia de combinação do câncer que envolve proteínas de ligação multiespecíficas que ativam células natural killer
|
|
CA3237846A1
(en)
|
2018-02-08 |
2019-08-15 |
Dragonfly Therapeutics, Inc. |
Antibody variable domains targeting the nkg2d receptor
|
|
WO2019164930A1
(en)
|
2018-02-20 |
2019-08-29 |
Dragonfly Therapeutics, Inc. |
Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use
|
|
CA3104297A1
(en)
|
2018-06-21 |
2019-12-26 |
Icahn School Of Medicine At Mount Sinai |
Mosaic influenza virus hemagglutinin polypeptides and uses thereof
|
|
EP3833392A4
(en)
|
2018-08-08 |
2022-05-18 |
Dragonfly Therapeutics, Inc. |
MULTISPECIFIC BINDING PROTEINS FOR BINDING CD33, NKG2D AND CD16 AND METHODS OF USE
|
|
EA202091888A1
(ru)
|
2018-08-08 |
2020-10-23 |
Драгонфлай Терапьютикс, Инк. |
Вариабельные домены антител, нацеленные на рецептор nkg2d
|
|
KR102835308B1
(ko)
|
2018-08-08 |
2025-07-21 |
드래곤플라이 쎄라퓨틱스, 인크. |
Nkg2d, cd16 및 종양 관련 항원에 결합하는 단백질
|
|
CN111057718A
(zh)
*
|
2018-10-17 |
2020-04-24 |
南京大学 |
一种稳定表达绿色荧光蛋白的egfp-sp2/0细胞株及其构建方法
|
|
KR102113302B1
(ko)
*
|
2018-12-24 |
2020-05-20 |
원광대학교산학협력단 |
상보성결정부 기반 조류 인플루엔자 바이러스의 h5 아형에 특이적으로 결합하는 펩티드 및 이의 용도
|
|
US11230593B2
(en)
|
2019-03-25 |
2022-01-25 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
US12545718B2
(en)
|
2019-04-24 |
2026-02-10 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza B virus neuraminidase antibodies and uses thereof
|
|
CA3152957A1
(en)
|
2019-09-05 |
2021-03-11 |
Janssen Vaccines & Prevention B.V. |
Influenza virus vaccines and uses thereof
|
|
US11642407B2
(en)
|
2020-02-28 |
2023-05-09 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
|
CN111440228B
(zh)
*
|
2020-03-09 |
2021-08-24 |
扬州大学 |
多种亚型流感病毒ha2蛋白共同抗原表位、抗体、鉴定方法和应用
|
|
WO2021201677A1
(en)
|
2020-04-01 |
2021-10-07 |
Kiadis Pharma Intellectual Property B.V. |
Compositions and methods targeting influenza
|
|
WO2021216103A1
(en)
*
|
2020-04-20 |
2021-10-28 |
Mahna Satish |
Controlled exposure to pathogens for generating immunity
|
|
JP7512394B2
(ja)
|
2020-05-06 |
2024-07-08 |
ドラゴンフライ セラピューティクス， インコーポレイテッド |
Ｎｋｇ２ｄ、ｃｄ１６及びｃｌｅｃ１２ａに結合するタンパク質
|
|
US20240043416A1
(en)
*
|
2021-02-04 |
2024-02-08 |
Sichuan Haisco Pharmaceutical Co., Ltd. |
Salt and crystal form of ha inhibitor compound
|
|
EP4301774A4
(en)
|
2021-03-03 |
2025-08-13 |
Dragonfly Therapeutics Inc |
METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS THAT BIND TO NKG2D, CD16, AND A TUMOR-ASSOCIATED ANTIGEN
|
|
WO2022232557A1
(en)
*
|
2021-04-30 |
2022-11-03 |
Adagio Therapeutics, Inc. |
Compounds specific to coronavirus s protein and uses thereof
|
|
CN120202213A
(zh)
|
2022-11-14 |
2025-06-24 |
扬森疫苗与预防有限公司 |
乙型流感病毒疫苗及其用途
|
|
WO2025019631A1
(en)
|
2023-07-19 |
2025-01-23 |
Icahn School Of Medicine At Mount Sinai |
Immunogenic compositions containing inactivated influenza a virus and cpg oligonucleotide adjuvant and uses thereof
|
|
WO2025051975A1
(en)
|
2023-09-06 |
2025-03-13 |
Sanofi |
Modified influenza b hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
WO2025090499A1
(en)
*
|
2023-10-24 |
2025-05-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Monoclonal antibodies that bind an antigen of epithelial ovarian cancer and their use
|
|
WO2025149667A1
(en)
|
2024-01-12 |
2025-07-17 |
Pheon Therapeutics Ltd |
Antibody drug conjugates and uses thereof
|
|
WO2026027730A1
(en)
|
2024-07-31 |
2026-02-05 |
Sanofi |
Modified h5 influenza hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
WO2026052773A1
(en)
|
2024-09-06 |
2026-03-12 |
Sanofi |
Modified influenza a hemagglutinin polypeptides and nucleic acids and uses thereof
|